Sell: One-half of Trovagene (TROV)
from Top Stocks under $10
Updated from WSBI 777, January 20, 2016
Trovagene (TROV) is up more than 12% for us. Remember, we had legged into this position as low as $3.26, but also as high as $4.04 before the biotech meltdown began. The future prospects for its cancer detection tests are still sound; this is just a move to give us flexibility to play the volatility. We will be selling half our holdings of Trovagene Inc. (TROV) in our Stocks Under $10 portfolio at $4.33 or better.
Sell: 2% of Alcoa (AA)
from Top Stocks under $10
Updated from WSBI 778, February 17, 2016
Alcoa (AA) is giving away a bit today but has been on a tear since it made a 52-week low at $6.15, up 32% from there. It’s not quite in the green for us. But being that this market is unsteady and even good stocks like AA are at the risk of downside, I’m moving a small portion (2%) of the position to cash. We could re-enter should it test recent lows again. We will be selling 2% of our holdings allocated to Alcoa Inc. (AA) at $8.00 or better.
Mandeep Rai, Top Stocks under $10, published by Money and Markets, a Division of Weiss Research, Inc., www.moneyandmarkets.com/services/trading-services/top-stocks-under-10, issues@e.moneyandmarkets.com; 1-800-291-8545, February 18, 2016